Prostate Cancer - Results from #200

Predictors of survival, healthcare resource utilization, and healthcare costs in veterans with non-metastatic castration-resistant prostate cancer. August 9, 2020

Alcohol Consumption and the Risk of Prostate Cancer: A Dose-Response Meta-Analysis. August 7, 2020

Assessing Apps for Patients with Genitourinary Tumors Using the Mobile Application Rating Scale (MARS): Systematic Search in App Stores and Content Analysis. August 7, 2020

[It is unclear whether pelvic lymphadenectomy is of oncological benefit in prostate cancer]. August 7, 2020

Inguino-scrotal bladder hernia: an unexpected finding on 68Ga-PSMA-11 PET/CT. August 7, 2020

PET Imaging Agents (FES, FFNP, and FDHT) for Estrogen, Androgen, and Progesterone Receptors to Improve Management of Breast and Prostate Cancers by Functional Imaging. August 7, 2020

Can fewer transperineal systematic biopsy cores have the same prostate cancer detection rate as of magnetic resonance imaging/ultrasound fusion biopsy? August 6, 2020

Automated [18F]PSMA-1007 production by a single use cassette-type synthesizer for clinical examination. August 6, 2020

PSMA-Directed CAR T Cells Combined with Low-Dose Docetaxel Treatment Induce Tumor Regression in a Prostate Cancer Xenograft Model. August 6, 2020

The FGF/FGFR System in the Physiopathology of the Prostate Gland. August 6, 2020

Moving away from systematic biopsies: image-guided prostate biopsy (in-bore biopsy, cognitive fusion biopsy, MRUS fusion biopsy) -literature review. August 6, 2020

Toxicity of pelvic lymph node irradiation with intensity modulated radiation therapy for high-risk and locally advanced prostate cancer: a national population-based study using patient-reported outcomes. August 6, 2020

Implication of Prophetic Variables and Their Impulsive Interplay in CA Prostate Patients Experiencing Osteo-Metastasis. August 6, 2020

Is prostate brachytherapy a dying art? Trends and variation in the definitive management of prostate cancer in ontario, canada. August 6, 2020

AR-V7 as a biomarker for resistance to treatment with abiraterone/enzalutamide in three Latin American countries: a hypothetical cost-saving analysis. August 5, 2020

Radiotherapy of Prostate Carcinoma: A Comparison of the Predictive Role of EAU Versus NCCN Risk Stratification Systems. August 5, 2020

Comparison of Tolerability Between 2-Weekly and 3-Weekly Docetaxel Regimen in Castration-resistant Prostate Cancer. August 5, 2020

Gain-loss framing and patients' decisions: a linguistic examination of information framing in physician-patient conversations. August 5, 2020

Predictors of ISUP score upgrade in patients with low-risk prostate cancer. August 5, 2020

AZGP1 Protein Expression in Hormone-Naïve Advanced Prostate Cancer Treated with Primary Androgen Deprivation Therapy. August 5, 2020

Page 11 of 1104